CN110354156A - A kind of myogenic powder formula and its production technology - Google Patents

A kind of myogenic powder formula and its production technology Download PDF

Info

Publication number
CN110354156A
CN110354156A CN201910747169.6A CN201910747169A CN110354156A CN 110354156 A CN110354156 A CN 110354156A CN 201910747169 A CN201910747169 A CN 201910747169A CN 110354156 A CN110354156 A CN 110354156A
Authority
CN
China
Prior art keywords
powder
gypsum
formula
myogenic
cinnabar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910747169.6A
Other languages
Chinese (zh)
Inventor
邢涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201910747169.6A priority Critical patent/CN110354156A/en
Publication of CN110354156A publication Critical patent/CN110354156A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/28Mercury; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of myogenic powder formulas, including formula as below ratio, gypsum 50-150 mass parts, borneol 5-10 mass parts, cinnabar 5-10 mass parts, Radix Notoginseng powder 3-6 mass parts, this product processing technology is simple, using simple, has the stronger wound healing promoting ability of dredging collateral and promoting blood circulation, festering for liquefaction of fat, skin or mucous membrane, effect is good, there is promotion granulation tissue fast-growth and the less scar in part to be formed, to human body without obvious toxic-side effects.

Description

A kind of myogenic powder formula and its production technology
Technical field
The present invention relates to traditional Chinese medicine formulation art, in particular to a kind of myogenic powder formula and its production technology.
Background technique
Shengji San is external application Chinese medicine prescription, is mainly used for boil and bursts long, and muscle is not given birth to, and the illnesss such as do not close up long, and tradition is raw Flesh dissipates common drug, and this will be for gypsum and cinnabar, and anastalsis is weaker, and wound healing promoting is indifferent, to liquefaction of fat Effect is undesirable, to mucocutaneous ulceration or fester it is ineffective, for promoting granulation tissue growth result not affirm, without mitigation Scar formation effect.
Summary of the invention
The technical problem to be solved by the present invention is to provide a kind of myogenic powder formulas to have dredging collateral and promoting blood circulation stronger using simply Wound healing promoting ability, for liquefaction of fat, skin or mucous membrane fester effect is good, rapidly promote granulation tissue growth and part It is formed with scar is mitigated, to human body without obvious toxic-side effects.
The technical solution adopted by the present invention to solve the technical problems is: a kind of myogenic powder formula, including formula as below ratio Example, gypsum 50-150 mass parts, borneol 5-10 mass parts, cinnabar 5-10 mass parts, Radix Notoginseng powder 3-6 mass parts.
Further, the gypsum is gypsum.
Further, the gypsum includes gypsum and calcined gypsum, the calcined gypsum account for gypsum total mass fraction 0~ 33%.
Further, every part of the formula includes gypsum 100g, borneol 8g, cinnabar 8g, Radix Notoginseng powder 6g.
Further, every part of the formula includes gypsum 50g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 3g.
Further, every part of the formula includes gypsum 150g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 6g.
The invention also discloses a kind of production technologies of myogenic powder formula, for producing the above-mentioned myogenic powder formula stated, Include:
A certain proportion of gypsum, borneol, cinnabar and Radix Notoginseng powder are broken into powder by step 1 respectively;
Gypsum powder, borneol powder, Cinnabar and Radix Notoginseng powder powder are sufficiently mixed uniformly by step 2;
Mixture in step 2 is sieved, removes its thick slag, only stay fine powder by step 3;
Step 4 crushes the filtrate in step 3 again until adding former fine powder mixing at uniformly powdered In object;
Step 5 packs uniform mixture.
The beneficial effects of the present invention are: this product processing technology is simple, using simple, there is stronger rushs of dredging collateral and promoting blood circulation to hurt Mouthful healing ability, it is good for liquefaction of fat, skin or mucous membrane effect of festering, to human body without obvious toxic-side effects.
Detailed description of the invention
Fig. 1 is the production technological process of myogenic powder formula.
Specific embodiment
The present invention is further described with reference to the accompanying drawings and detailed description.
This application discloses a kind of myogenic powder formula, including formula as below ratio, gypsum 50-150 mass parts, borneol 5-10 Mass parts, cinnabar 5-10 mass parts, Radix Notoginseng powder 3-6 mass parts;
The stone has the function of cream inducing diaphoresis expelling pathogenic factors from muscles and skin myogenic, gold wound;
The borneol has treatment sore swell and ache curative, the effect that do not hold back after bursting;
The cinnabar has the function of help healthy tendency, promoting blood circulation, sterilization;
The Radix Notoginseng powder has the function of hemostasis, dissipates the stasis of blood, analgesic therapy;
Above-mentioned gypsum selects gypsum, can also add a certain proportion of calcined gypsum in the case where gypsum is inadequate, described Calcined gypsum accounts for the 0~33% of gypsum total mass fraction.
There is the stronger wound healing promoting ability of dredging collateral and promoting blood circulation by the formula of measurement the application a series of, for fat liquor Change, skin or mucous membrane fester, and effect is good, can rapidly promote granulation tissue growth and part has mitigation scar formation effect, to people Body is without obvious toxic-side effects, and the following are specific detection embodiments:
1 gram of Shengji San and Yunnan Baiyao of the invention are equally taken, applied to the liquefaction of fat wound in 3cm, Yunnan Baiyao Powder is without promotion liquefaction of fat wound healing effect, and Shengji San of the present invention only uses for 1 times/day, can promote wound granulation within 2-3 days Organize fast-growth.
1 gram of Shengji San and scar plaster one of the invention is equally taken to open, scar plaster is only used for intact skin, and Shengji San can To apply at once after wound, Shengji San more rapidly promotes wound healing, so that scar is formed after less healing.
Equally take 1 gram of Shengji San of the invention and traditional Shengji San, applied to the wound in same 3cm, life of the invention Flesh, which dissipates, only needs 1 times/day of use, and wound can heal within 2-3 days, and traditional Shengji San wound healing needs 3-5 days, therefore the present invention Shengji San promote more traditional Shengji San the time required to wound healing short, hence it is evident that better than traditional Shengji San.
The specific embodiment of above-mentioned formula are as follows:
Embodiment 1:
Every part of the formula includes gypsum 100g, borneol 8g, cinnabar 8g, Radix Notoginseng powder 6g.
Embodiment 2:
Every part of the formula includes gypsum 50g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 3g.
Embodiment 3:
Every part of the formula includes gypsum 150g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 6g.
The invention also discloses a kind of production technologies of myogenic powder formula, for producing the above-mentioned myogenic powder formula stated, Include:
A certain proportion of gypsum, borneol, cinnabar and Radix Notoginseng powder are broken into powder by step 1 respectively;
Gypsum powder, borneol powder, Cinnabar and Radix Notoginseng powder powder are sufficiently mixed uniformly by step 2;
Mixture in step 2 is sieved, removes its thick slag, only stay fine powder by step 3;
Step 4 crushes the filtrate in step 3 again until adding former fine powder mixing at uniformly powdered In object;
Step 5 packs uniform mixture.
The production technology that this formula uses also has and uses without using to complicated equipment, processing technology is simple Simple feature.
Particular embodiments described above has carried out further in detail the purpose of the present invention, technical scheme and beneficial effects It describes in detail bright, it should be understood that the above is only a specific embodiment of the present invention, is not intended to restrict the invention, it is all Within the spirit and principles in the present invention, any modification, equivalent substitution, improvement and etc. done should be included in guarantor of the invention Within the scope of shield.

Claims (7)

1. a kind of myogenic powder formula, it is characterised in that: including formula as below ratio, gypsum 50-150 mass parts, borneol 5-10 matter Measure part, cinnabar 5-10 mass parts, Radix Notoginseng powder 3-6 mass parts.
2. a kind of myogenic powder formula as described in claim 1, it is characterised in that: the gypsum is gypsum.
3. a kind of myogenic powder formula as described in claim 1, it is characterised in that: the gypsum includes gypsum and calcined gypsum, The calcined gypsum accounts for the 0~33% of gypsum total mass fraction.
4. a kind of myogenic powder formula as described in any one of claim 2 to 3 claim, it is characterised in that: Every part of the formula includes gypsum 100g, borneol 8g, cinnabar 8g, Radix Notoginseng powder 6g.
5. a kind of myogenic powder formula as described in any one of claim 2 to 3 claim, it is characterised in that: Every part of the formula includes gypsum 50g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 3g.
6. a kind of myogenic powder formula as described in any one of claim 2 to 3 claim, it is characterised in that: Every part of the formula includes gypsum 150g, borneol 5g, cinnabar 5g, Radix Notoginseng powder 6g.
7. a kind of production technology of myogenic powder formula, for producing claim 1 to the life described in any one of claim 6 Flesh powder formula, it is characterised in that:
A certain proportion of gypsum, borneol, cinnabar and Radix Notoginseng powder are broken into powder by step 1 respectively;
Gypsum powder, borneol powder, Cinnabar and Radix Notoginseng powder powder are sufficiently mixed uniformly by step 2;
Mixture in step 2 is sieved, removes its thick slag, only stay fine powder by step 3;
Step 4 crushes the filtrate in step 3 again until adding former fine powder mixture at uniformly powdered In;
Step 5 packs uniform mixture.
CN201910747169.6A 2019-08-14 2019-08-14 A kind of myogenic powder formula and its production technology Pending CN110354156A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910747169.6A CN110354156A (en) 2019-08-14 2019-08-14 A kind of myogenic powder formula and its production technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910747169.6A CN110354156A (en) 2019-08-14 2019-08-14 A kind of myogenic powder formula and its production technology

Publications (1)

Publication Number Publication Date
CN110354156A true CN110354156A (en) 2019-10-22

Family

ID=68223742

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910747169.6A Pending CN110354156A (en) 2019-08-14 2019-08-14 A kind of myogenic powder formula and its production technology

Country Status (1)

Country Link
CN (1) CN110354156A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113318128A (en) * 2021-07-02 2021-08-31 陕西中医药大学附属医院 External application wound medicine powder bag

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1131022A (en) * 1995-03-16 1996-09-18 李锋 Qufushengjisan powder medicine capable of removing putrid tissues and promoting growth of new tissues and shengjisan powder
CN1166973A (en) * 1996-05-30 1997-12-10 刘全有 Multifunctional ointment for treating burn and scald
CN105148147A (en) * 2015-10-21 2015-12-16 覃佳林 Traditional Chinese medicine for treating wound or bedsore infection and preparation method thereof
CN109908270A (en) * 2019-04-30 2019-06-21 张华利 A kind of medicament for treating scald

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1131022A (en) * 1995-03-16 1996-09-18 李锋 Qufushengjisan powder medicine capable of removing putrid tissues and promoting growth of new tissues and shengjisan powder
CN1166973A (en) * 1996-05-30 1997-12-10 刘全有 Multifunctional ointment for treating burn and scald
CN105148147A (en) * 2015-10-21 2015-12-16 覃佳林 Traditional Chinese medicine for treating wound or bedsore infection and preparation method thereof
CN109908270A (en) * 2019-04-30 2019-06-21 张华利 A kind of medicament for treating scald

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
余元勋等: "《中国分子中药学》", 30 June 2017, 安徽科学技术出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113318128A (en) * 2021-07-02 2021-08-31 陕西中医药大学附属医院 External application wound medicine powder bag

Similar Documents

Publication Publication Date Title
CN102895460B (en) Traditional Chinese medicine composition for fracture and soft tissue injury
CN110354156A (en) A kind of myogenic powder formula and its production technology
CN103341096B (en) Medicine for treating hyperplasia of mammary glands and preparation method thereof
CN101926867A (en) Bone fracture recovering soup
CN106177725A (en) A kind of treat the plaster compositions of mastopathy, purposes and preparation method thereof
CN103223076B (en) Orally taken traditional Chinese medicine treating fractures
CN104587226A (en) Traditional Chinese medicine for treating ankylosing myelitis and lumbar disc herniation and use method thereof
CN104491423A (en) Traditional Chinese medicine composition for stomach and duodenal bulbar ulcers
CN100556425C (en) A kind of Chinese medicine unguentum of analgetic, hemostatic repercussive and sore-arresting functions
CN103285203A (en) Traditional Chinese medicine composition for preventing and treating bone fracture and preparation method thereof
CN108066549A (en) A kind of drug for treating endocrine disorder
CN103417788B (en) One treats fracture Chinese medicine for oral administration
CN101181456B (en) Plaster for curing bone fracture assimilation and preparation method thereof
CN104587128B (en) A kind of medical composition and its use treated first and subtracted
CN108553585A (en) It is a kind of to treat lipoma and fibromatous Chinese medicine preparation and preparation method thereof
CN102139088B (en) Cervical and lumbar vertebrae rehabilitation pill
CN1151816C (en) Fracture setting Chinese medicine capsule for treating bone injury and its prepn process
CN105213718A (en) For the Chinese medicine composition of malignant arrhythmia
CN105796860A (en) Quick-acting bone setting Yi medicine
CN105327288A (en) Drug for treating breast hyperplasia
CN104840624A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN104547358A (en) Traditional Chinese medicine preparation for treating spleen-kidney yang deficiency type postmenopausal osteoporosis
CN105079204A (en) Medicine for treating rheumatic and rheumatoid arthritis and preparation method of medicine
CN104906276A (en) Traditional Chinese medicine composition for treating phantom limb pain
CN101732408B (en) Chinese medicament for treating angitis and limb angiopathy and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20191022